AQP4 and ischemic stroke: Nonetheless, TGN‐020 remains a valuable pharmacological tool for studying glymphatic function, as demonstrated in various neurological models,[40] including ischemic stroke.[6, 41] In our experiments, TGN‐020 administration reversed the improvements induced by hybrid stimulation in AQP4 polarization, glymphatic clearance, and poststroke recovery outcomes.